Gujarat Alkalies and Chemicals · NSE: GUJALKALI · BSE: 530001
Q4 FY24 results · Jan–Mar 2024
Gujarat Alkalies and Chemicals reported revenue from operations of ₹1,001.62 crore (down 12.0% from Q4 FY23) and net loss of ₹46.19 crore for Q4 FY24 (Jan–Mar 2024), on a consolidated basis.
| Item | Q4 FY24 | Q4 FY23 | YoY | Q3 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,001.62 | 1,138.12 | −12.0% | 920.90 | +8.8% |
| Other income | 2.54 | 8.13 | −68.8% | 4.70 | −46.0% |
| Total income | 1,004.16 | 1,146.25 | −12.4% | 925.60 | +8.5% |
| Profit before share of associates & JVs and tax | (77.41) | 155.46 | Turned loss | (95.25) | Loss narrowed |
| Share of profit/(loss) of associates & JVs | (24.95) | (40.85) | (27.26) | ||
| Net profit for the period | (46.19) | 71.04 | Turned loss | (115.12) | Loss narrowed |
| EPS, basic (₹) | (6.29) | 9.68 | Turned loss | (15.68) | Loss narrowed |
| Net margin (%) | -4.6 | 6.2 | -12.5 |
This company reports a share of profit/(loss) from associates and joint ventures. BSE’s filing format records that share after tax, so it is shown on its own line. The company’s own statement may add it before its “profit before tax” line.
| Item | Q4 FY24 | Q4 FY23 | YoY | Q3 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,001.62 | 1,138.12 | −12.0% | 920.90 | +8.8% |
| Other income | 2.54 | 8.13 | −68.8% | 4.70 | −46.0% |
| Total income | 1,004.16 | 1,146.25 | −12.4% | 925.60 | +8.5% |
| Profit before tax | (77.41) | 155.46 | Turned loss | (95.25) | Loss narrowed |
| Net profit for the period | (21.24) | 111.89 | Turned loss | (87.86) | Loss narrowed |
| EPS, basic (₹) | (2.90) | 15.23 | Turned loss | (11.96) | Loss narrowed |
| Net margin (%) | -2.1 | 9.8 | -9.5 |
Consolidated
- Filed with BSE
- 01 Jun 2024, 11:46 IST
- Board meeting
- 30 May 2024
- Period
- 01 Jan 2024 to 31 Mar 2024
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 01 Jun 2024, 11:46 IST
- Board meeting
- 30 May 2024
- Period
- 01 Jan 2024 to 31 Mar 2024
- Review status
- Audited
- Source
- XBRL filing on BSE